Cargando…
Oral vinorelbine plus cisplatin with concomitant radiotherapy as induction therapy for stage III non‐small cell lung cancer: Results of a single‐arm prospective cohort study
BACKGROUND: Concurrent chemoradiotherapy (CCRT) is an optimal recommended treatment for stage III non‐small cell lung cancer (NSCLC). Herein, we aimed to investigate the efficacy and safety of oral vinorelbine plus cisplatin with concomitant radiotherapy for stage III NSCLC. METHODS: This prospectiv...
Autores principales: | Hsu, Ping‐Chih, Chang, John Wen‐Chang, Wang, Chun‐Chieh, Wu, Chen‐Te, Lin, Yu‐Ching, Wang, Chih‐Liang, Lin, Tin‐Yu, Li, Shih‐Hong, Wu, Yi‐Chen, Kuo, Scott Chih‐Hsi, Yang, Cheng‐Ta, Liu, Chien‐Ying, Chen, Chih‐Hung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669803/ https://www.ncbi.nlm.nih.gov/pubmed/31276309 http://dx.doi.org/10.1111/1759-7714.13125 |
Ejemplares similares
-
Comparison of vinorelbine with cisplatin in concomitant chemoradiotherapy in head and neck carcinoma
por: Devleena,, et al.
Publicado: (2010) -
Successful Concurrent Chemoradiotherapy with Cisplatin plus Vinorelbine for Locally Advanced Thymic Carcinoma
por: Fukushima, Toshirou, et al.
Publicado: (2014) -
Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer
por: Zhao, Qian, et al.
Publicado: (2016) -
A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer
por: Lerouge, Delphine, et al.
Publicado: (2014) -
Incidence and Risk Factors for Extremity Osteoradionecrosis after Limb-Sparing Surgery and Adjuvant Radiotherapy
por: Lu, Yun-Jui, et al.
Publicado: (2023)